Introduction
The c-myc proto-oncogene encodes the c-Myc oncoprotein that exerts considerable control over transformation, differentiation, apoptosis, and cell cycle progression. [1] [2] [3] [4] The Myc family proteins, including c-, N-and L-Myc, heterodimerize with the carboxy-terminal basic/helix-loop-helix/leucine zipper (bHLHZip) domain of Max protein. [5] [6] [7] [8] Max-Max homodimer and Myc-Max heterodimers bind with a specific DNA sequence, CACGTG (E-box), 5, 9, 10 but the heterodimerization and DNA binding of Max are required for transcriptional activation of target genes by c-Myc, as well as its ability to promote proliferation, malignant transformation and apoptosis. 11, 12 The myc gene is amplified in many tumors, particularly small-cell lung carcinoma, breast and cervical carcinomas. [13] [14] [15] Activated oncogenic c-Myc is instrumental in the progression of Burkitt's lymphoma 16 and its expression is elevated or deregulated in a wide range of other human cancers and is often associated with aggressive, poorly differentiated tumors. 17 The inhibition of proliferation and induction of apoptosis are regulated by a network of signaling pathways and transcription factors, which are possible targets for a rational tumor therapy. 18, 19 For instance, some anticancer reagents cause cell death through interfering with the processes of the cell cycle 20 and some others cause cell death by apoptosis, 21, 22 which plays an important role in the balance between cell replication and cell death. Leukemia, one of the most threatening hematological malignant cancers, has been found to be very sensitive to anticancer reagents which either block the process of the cell cycle or cause apoptosis. 23 This chemotherapy-sensitive property of leukemia entices researchers to look for more specific and potent drugs against it. As potent new drug candidates, natural compounds have been highlighted because of their low degree of cytotoxicity.
In this study, we prepared recombinant c-Myc and Max encompassing the DNA binding (basic) and dimerization (HLHZip) domain of human origin, and tested the inhibitory effect of fatty acids on the DNA binding of recombinant c-Myc/ Max dimers. The inhibitory effect of fatty acids on the DNA binding step has been described in a previous study. 24 Also, we demonstrated that these fatty acids suppressed proliferation and induced apoptosis of HL-60 cells, whose differentiation had been stimulated by 1% DMSO, 25 with no influence on the expression of c-Myc.
Materials and methods

Construction of expression vector containing recombinant c-myc and max gene
Recombinant c-myc and max genes containing a DNA-binding basic domain, helix-loop-helix domain and leucine zipper domain (kindly provided by Dr Bruno Amati) were cloned into pET21a( þ ) vectors. The constructed vectors were transformed into Escherichia coli (E. coli) BL21(DE3) for the protein expression. The analyzed DNA sequences of recombinant cmyc and max were ATG GCT AGC ATG ACT GGT GGA CAG  CAA ATG GGT CGC GGA TCC GAA TTC GGA TCC ACC ATG  GGA AAT GTC AAG AGG CGA ACA CAC AAC GTC TTG GAG  CGC CAG AGG AGG AAC GAG CTA AAA CGG AGC TTT TTT  GCC CTG CGT GAC CAG ATC CCG GAG TTG GAA AAC AAT  GAA AAG GCC CCC AAG GTA GTT ATC CTT AAA AAA GCC  ACA GCA TAC ATC CTG TCC GTC CAA GCA GAG GAG CAA  AAG CTC ATT TCT GAA GAG GAC TTG TTG CGG AAA CGA  CGA GAA CAG TTG AAA CAC AAA CTT GAA CAG CTA CGG  AAC TCT TGT GCG CTC GAG CAC CAC CAC CAC CAC CAC  and ATG GCT AGC ATG ACT GGT GGA CAG CAA ATG GGT  CGC GGA TCC ACC ATG GGA GAC AAA CGG GCT CAT CAT  AAT GCA CTG GAA 
Preparation of recombinant c-Myc and Max proteins
Each colony containing recombinant human c-myc and max gene was grown in an LB culture media containing 0.1 mg ml À1 ampicillin at 371C until their OD 600 reached 0.6. Following incubation with 1 mM IPTG for 7 h, the cultures were harvested at 41C by ultracentrifuge. The harvested cells including recombinant Max (Max85) and recombinant c-Myc (Myc87) were resuspended with Binding buffer solution (0.5 M NaCl, 20 mM Tris hydrochloride (pH 7.9) and 5 mM imidazole) and with Binding buffer solution containing 6 M urea, respectively. Since recombinant proteins were produced with a His-tag, they were easily purified using nickel-ion affinity chromatography (Novagen, Germany) at 41C. Eluted buffer solutions containing Myc87 and Max85 were dialyzed into Binding buffer solution, and each Binding buffer solution containing proteins was diluted and dialyzed into TBS (Tris-buffered saline; 137 mM NaCl, 2.68 mM KCl and 10 mM Tris-HCl, pH adjusted to 7.4) Preparation of HL-60 cell line and whole cell lysate HL-60 cells was incubated in RPMI1640 (WelGENE, Korea) media supplemented with 20% fetal bovine serum (WelGENE, Korea) at 371C in a 5% CO 2 humidified incubator. The whole cell proteins were obtained by lysing the cells on ice for 20 min in lysis buffer (50 mM Tris-HCl, pH 7.4, 0.15 M NaCl, 1% Nonidet P-40, 0.5 mM PMSF 50 mg/ml aprotinin, 10 mg/ml leupeptin, 50 mg/ml pepstatin, 0.4 mM sodium orthovanadate, 10 mM sodium fluoride, and 10 mM sodium pyrophosphate). The lysates were then sonicated for 30 s, and spun at 15 000 g for 10 min, and the supernatant was saved. The concentration of the total proteins was determined by the Bradford method.
Western blot analysis
Proteins and Western size markers (West-view, Elpis-Biotech, Korea) were electrophoresed in a 12% SDS-polyacryamide gel. The separated proteins were electrotransferred from the SDSpolyacryamide gel to a nitrocellulose membrane ( 
Preparation of fatty acid stock solution
Stearic acid, myristic acid, g-linolenic acid, linoleic acid, linolenic acid and arachidonic acid were purchased from Sigma-Aldrich. Stock solutions were prepared in DMSO and their concentration was set to 10 mM.
Electrophoretic mobility shift assay (EMSA)
The proportions of protein-DNA complexes in each sample were determined by measurement of the intensity of bands on an autoradiograph generated by EMSA. Myc-Max consensus oligonucleotides (5 0 -dGGAAGCAGACCACGTGGTCTG CTTCC-3 0 , Santa Cruz Biotechnology) were labeled using [gamma-32 P] ATP (Amersham Biosciences) and T4 polynucleotide kinase (TaKaRa bio, Japan). Following incubation of the protein mixtures at RT for 5 min, the DMSO solution containing each fatty acid was added. After further incubation for 5 min, the labeled DNA was added. In order to achieve a state of equilibrium, we incubated the whole mixtures at RT for 10 min. The protein-DNA complexes were separated from the free DNA on a 6% polyacrylamide gel prepared and pre-electrophoresed in 0.5 Â TBE buffer. Electrophoresis was performed in the 0.5 Â TBE buffer at 100 V and 371C for 1 h. Each band was visualized by autoradiography, and the intensities of bands were measured by image analysis software (TotalLab, NonLinear Dynamics, UK).
Cell proliferation assay
Maintained HL-60 cells were harvested by ultracentrifuge and resuspended with growth medium (RPMI1640 þ 20% FBS). Aliquots of 1 Â 10 4 HL-60 cells in 100 ml were seeded per well. Fatty acids at a final concentration of 0-100 mM was added to each well, and the cells were incubated for 24 h. Cell viability was determined by XTT cell proliferation assay kit (Biological Industries, Israel). XTT (sodium 3 0 -1-(phenylaminocarbonyl)-3,4-tetrazolium-bis(4-methoxy-6-nitro)benzene sulfonic acid), a yellow tetrazolium salt, was cleaved by the mitochondrial dehydrogenase in metabolically active cells to form an orange formazon dye. The absorbance of each sample was measured with a spectrophotometer (EMax plate reader, Molecular Devices) at a wavelength of 450 nm.
DNA fragmentation assay
The progress of apoptosis was detected by a DNA fragmentation assay in total genomic DNA. HL-60 cells treated with fatty acids were harvested by centrifugation and lysed in lysis buffer (2 mM EDTA, 100 mM Tris-HCl (pH 8.0), 0.8% SDS) on ice. The lysate was incubated with 5 mg/ml RNase A (Sigma-Aldrich) for 1 h at 371C and then with 5 mg/ml proteinase K (Sigma-Aldrich) for 3 h at 501C. After addition of 6 Â Gel Loading buffer, the mixture was loaded into a 1.5% agarose gel followed by electrophoresis at 50 V for 1 h in 1 Â TBE buffer and ethidium bromide staining. 
Results
Recombinant c-Myc and Max proteins
Fatty acids inhibit DNA binding of Myc87/Max85 dimer
The inhibitory effect of fatty acids on the DNA binding of recombinant c-Myc/Max was confirmed by EMSA. Each fatty acid at a concentration of 0-100 mM was added to the mixture containing Myc87, Max85 and labeled DNA. The 50% inhibitory concentration (IC 50 ) was determined by analysis of its intensity on an autoradiograph using image analysis software. The analyzed IC 50 values were 97(73) mM for myristic acid, 2.2(71.2) mM for stearic acid, 55(75) mM for g-linolenic acid, 32(72) mM for linoleic acid, 62(712) mM for linolenic acid and 22(72) mM for arachidonic acid. The inhibitory effect of unsaturated fatty acids (g-linolenic acid, linoleic acid, linolenic acid and arachidonic acid) for DNA binding was similar at a same concentration, but the effect of saturated fatty acids was differed greatly (Figure3).
Fatty acids suppress proliferation of HL-60 cells
HL-60 cells spontaneously differentiate and differentiation can be stimulated by dimethylsulfoxide (DMSO, 1-1.5%). We added 1 ml DMSO solutions containing each fatty acid to aliquots of 1 Â 10 4 HL-60 cells in 100 ml growth media, and the final concentrations of fatty acids diluted into aliquots were 0, 1, 5, 10, 20, 30, 40, 50, 60, 80, 100 mM. Following incubation for 12 h, the cell viability in each well was determined by XTT assay. The rates of the proliferation of cells treated with stearic acid and with myristic acid remained at a consistently high level at all concentrations. As compared with cells treated with 1% DMSO, the viability of cells treated with 100 mM of myristic acid and stearic acid for 12 h was 47 and 73%. By contrast, the proliferation of cells was strongly inhibited by g-linolenic acid, linoleic acid, linolenic acid and arachidonic acid. The relative viability of the cells treated with 100 mM of these unsaturated fatty acids was only 10-12%. However, the inhibitory effects of unsaturated fatty acids on HL-60 cell proliferation differed in the range of IC 50 . In this range (20-60 mM), the inhibitory effect of linoleic acid and of arachidonic acid was stronger than that of glinolenic acid and of linolenic acid. This result is matched well with the order of IC 50 values and shows that the inhibitory effect of fatty acids on the proliferation of HL-60 cells has a relation with its inhibitory effect on the DNA binding of c-Myc/Max (Figure 4 ).
Fatty acids induce apoptosis of HL-60 cells
The progress of apoptosis was detected by DNA fragmentation assay of the total genomic DNA. A total of 60 ml DMSO solutions containing each fatty acid were added to aliquots of 3 Â 10 5 HL-60 cells in 6 ml, and the final concentrations of fatty acids diluted into aliquots were adjusted to 100 mM. In all, 3 ml of media were harvested from each aliquot before incubation and after incubation for 24 h, respectively. As shown in Figure 5 , there is a difference of degree in the progress of apoptosis ( Figure 5 ).
The degree of apoptosis in the media containing 100 mM of stearic acid and myristic acid was low relative to that in the media containing 100 mM of other unsaturated fatty acids. More precisely, the following order shows that in which fatty acid cells demonstrated the higher degree of apoptosis: linoleic acidElinolenic acidEarachidonic acid4g-linolenic acid4 stearic acid4myristic acid. This order of degree is analogous with that of IC 50 . Compared with the rate of cell proliferation, it is remarkable that the apoptosis of the cells treated with stearic acid makes rapid progress against myristic acid.
Fatty acids have no influence on the expression of c-Myc
To confirm the influence of fatty acids on the expression of c-Myc, we analyzed the amount of c-Myc protein in HL-60 cells treated with each fatty acid for 6 h. The amount of c-Myc in each aliquot was determined by Western blotting. The concentration of total protein in the each lysate was determined by the method of Bradford, and 60 mg of total protein extracted from the treated cells was loaded to each well of SDS-PAGE gel. There is no significant difference in the amount of c-Myc in each aliquot. This result demonstrates that fatty acids have no influence on the expression of c-Myc in DMSO-differentiated HL-60 cells ( Figure 6 ).
Discussion
It has been reported that several fatty acids suppress the proliferation of differentiated HL-60. For instance, it was reported that blocking the metabolism of eicosapentaenoic acid and g-linolenic acid by 5-lipoxygenase suppresses the proliferation and induced apoptosis of HL-60 cell, 26 and that when the activity of phospholipase A2, which participate in the metabolism of arachidonic acid, was blocked with a inhibitor, arachidonic acid suppresses the proliferation, 27 and induces apoptosis of HL-60 cell. 28 While the cause was not evident, or it has been considered that some fatty acids have influence on the metabolism or that the products from the metabolism of fatty acid suppress the proliferation, we hypothesized that the fatty acids suppressing proliferation of HL-60 cell may be the inhibitors for the DNA-binding step of the c-Myc/Max dimeric protein. We tested the inhibitory effect of fatty acids for the complexes formed with recombinant c-Myc and Max, and confirmed that the fatty acids which have a weak inhibitory effect have no influence on the proliferation of HL-60 cells. For instance, oleic acid has no effect as an inhibitor for the DNAbinding step of c-Myc/Max and did not suppress the proliferation of DMSO-differentiated HL-60 cells (data not shown). In our experiments, stearic acid, whose IC 50 was measured as 2.2(71.2) mM, is a potent inhibitor for DNA binding of c-Myc/ Max (Figure 3 ), but its influence on differentiated HL-60 was relatively weak. We performed many types of test enough to confirm the influence, but the results were the same every time. Ultimately, we concluded that the weak influence of stearic acid is caused by the rapid metabolism of saturated fatty acids. However, it is thought that the continuous oversupply of stearic acid induces the apoptosis of differentiated HL-60 cells ( Figure 5 ).
In summary, we confirmed that the fatty acids, which inhibit the DNA binding of c-Myc/Max, suppress the proliferation and induce the apoptosis of differentiated HL-60, and we concluded that the inhibitors for the DNA binding of c-Myc/Max suppress the Myc-induced proliferation. In further studies, we will focus on what inhibits the DNA binding of c-Myc/Max specifically and potently. The progress and the rate of apoptosis by fatty acids were detected with DNA fragmentation assay in total genomic DNA. DMSO solution containing 100 mM of each fatty acid was added to each growth media at a concentration of 1% and the spontaneous differentiation of HL-60 cells was stimulated. Cells in the media containing 100 mM of each fatty acid were harvested before incubation (a, c, e, g, i, k) and after incubation for 24 h (b, d, f, h, j, l). The fatty acids contained in the media were myristic acid (a, b), stearic acid (c, d), g-linolenic acid (e, f), linoleic acid (g, h), linolenic acid (i, j) and arachidonic acid (k, l). Figure 6 The amount of c-Myc protein in HL-60 cells treated with fatty acids. DMSO-differentiated HL-60 cells were incubated in the media containing 100 mM of each fatty acid, and were harvested after 6 h. The amount of c-Myc in the cells treated with DMSO (as control) and each fatty acid was measured by Western blot analysis. The concentration of total proteins loaded into each well was adjusted to 60 mg, and a nitrocellulose membrane stained with Ponceau S was shown to confirm an equal amount of protein loading. The relative amount of c-Myc was 0.93-1 with maximum value for a standard.
